TE_16

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1MC1_3end
TE superfamily L1
TE class LINE
Gene C1orf159
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 1.18
Counts of samples TCGA_tumor:110; TCGA_normal:4; GTEx:101
TSS chr1(-):1100489



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_16.1 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1090876,1090983,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.2 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.3 C1orf159 Chimeric Other MALRHLALLAGLLVGVASKSMENTAQLPECCVDVVGVNASCPGASLCGPGCYRRWNADGSASCVRCGNGTLPAYNGSECRSFAGPGAPFPMNRSSGTPGRPHPGAPRVAASLFLGTFFISSGLILSVAGFFYLKRSSKLPRACYRRNKAPALQPGEAAAMIPPPQSSDVGSAGKEDPPRQGRPPIPAPP* chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.4 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.5 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1091374,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.6 C1orf159 Chimeric Non-coding Non-coding chr1(-):1082967,1082987,1083915,1084011,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.7 C1orf159 Chimeric Non-coding Non-coding chr1(-):1084066,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.8 C1orf159 Chimeric Non-coding Non-coding chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490
teRNA_16.9 C1orf159 Chimeric Non-coding Non-coding chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091609,1091991,1092103,1100452,1100490
teRNA_16.10 C1orf159 Chimeric Non-coding Non-coding chr1(-):1087577,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1100452,1100490


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).